Yvette Fairfax: Wiskott-Aldrich Gene Therapy Changes Immunity, but Affordability May Determine Survival
Yvette Fairfax, Shareholder of KOELIS, shared a post on LinkedIn:
“The approval of the first gene therapy for Wiskott-Aldrich syndrome is a profound milestone for families facing a disorder linked to immune dysfunction, bleeding risk, and repeated infections.
For affected children, this kind of therapy is not just an incremental medical improvement. It has the potential to reduce hospital crises, improve stability, and reshape daily life in a much more fundamental way.But the controversy begins right after celebration.
Gene therapies often represent the best of science and the hardest realities of healthcare economics at the same time. A breakthrough can be medically transformative and still remain financially out of reach for families trapped in slow reimbursement systems or unequal access pathways.
In the U.S., UK, and Canada, rare-disease medicine keeps exposing the same structural tension: scientific innovation moves faster than fair access. If a one-time treatment can prevent years of suffering, complications, and repeated medical costs, waiting too long to fund it may be both unjust and inefficient.
Should public systems approve payment earlier for these therapies instead of forcing families through exhausting access battles first?”
Stay updated with Hemostasis Today.
-
Sep 4, 2026, 16:48ESC Congress 2026 – My Top 20 Lipidology Highlights Shaping the Future of Cardiovascular Prevention – Pablo Corral
-
Sep 4, 2026, 16:38Felice Gragnano։ Turning Cardiovascular Risk Into Action
-
Sep 4, 2026, 16:30Lisa Littner: The Hidden Burden of Prior Authorization in Bleeding Disorder Care
-
Sep 4, 2026, 13:54Ahmad G. Alzahrani: A New Classification for Acute Pulmonary Embolism
-
Sep 4, 2026, 12:52James P. Crowley: MDS vs MPN – Understanding the Difference
-
Sep 4, 2026, 12:02Khalid Abdelsamea Mohamedahmed: Routine Blood Parameters in Pediatric Sickle Cell Anemia
-
Sep 4, 2026, 11:37Consuela A. Albright: The Power of Community Advocacy in Sickle Cell Disease
-
Sep 4, 2026, 11:18Aanika Roshni: When Blood, Biology, and Mechanics Intersect
-
Sep 4, 2026, 10:01Ifeanyichukwu Ifechidere: Making Coagulation Simpler and More Practical